Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Matsuzaki, W. Tanaka, Y. Kojima, M. Kawakami, M. Suzuki, Y. Sakamoto, T. Horiuchi (Tokyo, Japan). Elevated CEA levels in sera in patients with allergic bronchopulmonary aspergillosis (ABPA). Eur Respir J 2011; 38: Suppl. 55, 473

Member's Comments

No comment yet.

Related content which might interest you: Surfactant protein D in serum from patients with allergic bronchopulmonary aspergillosis Source: Eur Respir J 2003 Oct 01;22(4):592-595 Year: 2003 Follow-up of patients with allergic bronchopulmonary aspergillosis (ABPA) - side effects of long-term therapy Source: Eur Respir J 2003; 22: Suppl. 45, 237s Year: 2003 Allergic bronchopulmonary aspergillosis (ABPA) prevalence in adult cystic fibrosis (CF) patients. Usefulness of recombinant Aspergillus fumigatus IgE (rAsp f) in diagnosis and monitoring treatment Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis Year: 2012 Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis Source: Eur Respir J 2008; 31: 36-42 Year: 2008 Clinical presentation in 12 patients with allergic bronchopulmonary aspergillosis Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007 Long term follow up of the lung function in cystic fibrosis patients with allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Complex treatment of allergic bronchopulmonary aspergillosis (ABPA) in asthmatic patient including anti-IgE therapy – A case report Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 Changes in total IgE levels predict pulmonary outcome in cystic fibrosis related allergic bronchopulmonary aspergillosis Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease? Source: Eur Respir Rev 2010 19: 261-263 Year: 2010 IgE expression in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2013 –Asthma Year: 2013 Serum levels of interleukin-18 in patients affected by allergic bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 30s Year: 2002 Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis Source: Eur Respir J 2016; 47: 177-185 Year: 2016 Association of pulmonary aspergilloma and allergic bronchopulmonary aspergillosis Source: Eur Respir Rev 2010 19: 349-351 Year: 2010 Diagnostic value of combined sIgG and sIgE of Aspergillus fumigatus in allergic broncho pulmonary aspergillosis and severe asthma with fungal sensitation Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 Retrospective study on the combined use of voriconazole and prednisolone in the treatment of acute allergic bronchopulmonary aspergillosis (ABPA). Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Clinical characteristics and outcome of patients with allergic bronchopulmonary aspergillosis Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017 Effects and side effects of long term steroid therapy of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis Source: Eur Respir J 2014; 43: 1487-1500 Year: 2014 Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis Source: Eur Respir J 2003; 21: 582-588 Year: 2003 Serum level directed itraconazole therapy in allergic bronchopulmonary aspergillosis Source: International Congress 2016 – Molecular immunology of the lung Year: 2016